This workshop wasn't recorded, and on-demand content only includes the handouts.

This conference workshop provides comprehensive insights into the emerging trends, regulatory differences, and technological advancements in the Chinese pharmaceutical and healthcare sector.

1300 – 1310: Welcome by Ping ZHANG
1310 – 1330: Development of ISPE China in recent 3 years by Hongyang LI
1330 – 1400: Comparative Analysis of NMPA/FDA Regulations-Pathway to Entry Chinese Market Successfully by Ping ZHANG
1400 – 1430: Gene and Cell Therapy in China – landscape and regulatory update by Frank GAO
1430 – 1445: Break
1445 – 1515: Manufacturing Excellence on Biologics Products with Single Use Technology and Robust Quality Operations by Sherry GU
1515 – 1545: High performance and Cost-effective Bioprocess Solutions by Peter FU
1545 – 1600: QA/Closing

Hongyang Li

Quality Head, Novartis

Appearances